{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:45:18Z","timestamp":1781624718823,"version":"3.54.5"},"reference-count":146,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Diabetic neuropathy is a persistent consequence of the biochemical condition known\nas diabetes mellitus. As of now, the identification and management of diabetic neuropathy continue\nto be problematic due to problems related to the safety and efficacy of existing therapies.\nThis study examines biomarkers, molecular and cellular events associated with the advancement\nof diabetic neuropathy, as well as the existing pharmacological and non-pharmacological treatments\nemployed. Furthermore, a holistic and mechanism-centric drug repurposing approach,\nantioxidant therapy, Gene and Cell therapies, Capsaicin and other spinal cord stimulators and\nlifestyle interventions are pursued for the identification, treatment and management of diabetic\nneuropathy. An extensive literature survey was done on databases like PubMed, Elsevier, Science\nDirect and Springer using the keywords \u201cDiabetic Neuropathy\u201d, \u201cBiomarkers\u201d, \u201cCellular\nand Molecular Mechanisms\u201d, and \u201cNovel Therapeutic Targets\u201d. Thus, we may conclude that\nnon-pharmacological therapies along with palliative treatment, may prove to be crucial in halting\nthe onset of neuropathic symptoms and in lessening those symptoms once they have occurred.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010316518240924071259","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T01:15:29Z","timestamp":1727745329000},"page":"2320-2338","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-1043","authenticated-orcid":true,"given":"Namra","family":"Aziz","sequence":"first","affiliation":[{"name":"Department of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), NH-19, Bhauti Road, Kanpur,UP, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shital Vijay","family":"Nehere","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, M.C.E. Society\u2019s, Allana College of Pharmacy, Azam Campus, Camp,Pune, 411001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishika","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), NH-19, Bhauti Road, Kanpur,UP, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Satyarthy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Government Pharmacy Institute, Agamkuan, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshit","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), NH-19, Bhauti Road, Kanpur,UP, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttam Prasad","family":"Panigrahy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Pharmaceutical science, Assam down town University, Sankar Madhab Path,Gandhi Nagar, Panikhaiti, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh Chandra","family":"Sharma","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Devi Ahilya Vishwavidalaya, Indore,452001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Adesh Institute of Pharmacy and Biomedical Sciences, Adesh University,NH-7, Barnala Road, Bathinda, 151001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Wal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), NH-19, Bhauti Road, Kanpur,UP, 209305, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"Feldman E.L.","year":"2019","unstructured":"Feldman E.L.; Callaghan B.C.; Pop-Busui R.; Zochodne D.W.; Wright D.E.; Bennett D.L.; Bril V.; Russell J.W.; Viswanathan V.; Diabetic neuropathy. Nat Rev Dis Primers  2019,5(1),41","journal-title":"Nat Rev Dis Primers"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"Callaghan B.C.","year":"2012","unstructured":"Callaghan B.C.; Cheng H.T.; Stables C.L.; Smith A.L.; Feldman E.L.; Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol  2012,11(6),521-534","journal-title":"Lancet Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.phrs.2015.09.014","volume":"102","author":"Negi G.","year":"2015","unstructured":"Negi G.; Nakkina V.; Kamble P.; Sharma S.S.; Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy. Pharmacol Res  2015,102,158-167","journal-title":"Pharmacol Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"Singh R.","year":"2014","unstructured":"Singh R.; Kishore L.; Kaur N.; Diabetic peripheral neuropathy: Current perspective and future directions. Pharmacol Res  2014,80,21-35","journal-title":"Pharmacol Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.3390\/ijms24043554","volume":"24","author":"Galiero R.","year":"2023","unstructured":"Galiero R.; Caturano A.; Vetrano E.; Beccia D.; Brin C.; Alfano M.; Di Salvo J.; Epifani R.; Piacevole A.; Tagliaferri G.; Rocco M.; Iadicicco I.; Docimo G.; Rinaldi L.; Sardu C.; Salvatore T.; Marfella R.; Sasso F.C.; Peripheral neuropathy in diabetes mellitus: Pathogenetic mechanisms and diagnostic options. Int J Mol Sci  2023,24(4),3554","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/978-3-031-08014-2_58","author":"Rajendram R.","year":"2023","unstructured":"Rajendram R.; Gyamfi D.; Patel V.B.; Preedy V.R.; Recommended resources for biomarkers in diabetes: Methods, discoveries, and applications. Biomarkers in Diabetes  2023,1141-1153","journal-title":"Biomarkers in Diabetes"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00107","author":"B\u00f6nhof G.J.","year":"2018","unstructured":"B\u00f6nhof G.J.; Herder C.; Strom A.; Papanas N.; Roden M.; Ziegler D.; emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocr Rev  2018","journal-title":"Endocr Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/ijms22052301","volume":"22","author":"Fujita Y.","year":"2021","unstructured":"Fujita Y.; Murakami T.; Nakamura A.; Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy. Int J Mol Sci  2021,22(5),2301","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3389\/fnins.2018.01038","volume":"12","author":"Richner M.","year":"2019","unstructured":"Richner M.; Ferreira N.; Dudele A.; Jensen T.S.; Vaegter C.B.; Gon\u00e7alves N.P.; functional and structural changes of the blood-nerve-barrier in diabetic neuropathy. Front Neurosci  2019,12,1038","journal-title":"Front Neurosci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3889\/oamjms.2019.646","volume":"7","author":"Ristikj-Stomnaroska D.","year":"2019","unstructured":"Ristikj-Stomnaroska D.; Risteska-Nejashmikj V.; Papazova M.; Role of inflammation in the pathogenesis of diabetic peripheral neuropathy. Open Access Maced J Med Sci  2019,7(14),2267-2270","journal-title":"Open Access Maced J Med Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdi.12794","volume":"9","author":"Jin H.Y.","year":"2018","unstructured":"Jin H.Y.; Park T.S.; Role of inflammatory biomarkers in diabetic peripheral neuropathy. J Diabetes Investig  2018,9(5),1016-1018","journal-title":"J Diabetes Investig"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2174\/138161208784139774","volume":"14","author":"Sugimoto K.","year":"2008","unstructured":"Sugimoto K.; Yasujima M.; Yagihashi S.; Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des  2008,14(10),953-961","journal-title":"Curr Pharm Des"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-26681-2_18","author":"Collazos-Alem\u00e1n J.D.","year":"2023","unstructured":"Collazos-Alem\u00e1n J.D.; Salazar-Ocampo M.P.; Mendivil C.O.; The role of lipids and lipoproteins in peripheral neuropathy. Lipoproteins in Diabetes Mellitus  2023","journal-title":"Lipoproteins in Diabetes Mellitus"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"106326","DOI":"10.1016\/j.phrs.2022.106326","volume":"182","author":"Garg S.S.","year":"2022","unstructured":"Garg S.S.; Gupta J.; Polyol pathway and redox balance in diabetes. Pharmacol Res  2022,182,106326","journal-title":"Pharmacol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"16730","DOI":"10.1038\/s41598-022-19947-2","volume":"12","author":"Vieira W.F.","year":"2022","unstructured":"Vieira W.F.; Malange K.F.; de Magalh\u00e3es S.F.; Lemes J.B.P.; dos Santos G.G.; Nishijima C.M.; de Oliveira A.L.R.; da Cruz-H\u00f6fling M.A.; Tambeli C.H.; Parada C.A.; Anti-hyperalgesic effects of photobiomodulation therapy (904 nm) on streptozotocin-induced diabetic neuropathy imply MAPK pathway and calcium dynamics modulation. Sci Rep  2022,12(1),16730","journal-title":"Sci Rep"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9989272","volume":"2022","author":"Qureshi Z.","year":"2022","unstructured":"Qureshi Z.; Ali M.N.; Khalid M.; An insight into potential pharmacotherapeutic agents for painful diabetic neuropathy. J Diabetes Res  2022,2022(1),1-9","journal-title":"J Diabetes Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/10942912.2023.2189569","volume":"26","author":"Akram R.","year":"2023","unstructured":"Akram R.; Anwar H.; Javed M.S.; Imran A.; Rasul A.; Malik S.A.; Manzoor M.; Islam F.; Khan I.U.; Sajid F.; Iman T.; Shah M.A.; Sun T.; Hussain G.; Shah M.A.; Natural molecules as promising players against diabetic peripheral neuropathy: an emerging nutraceutical approach. Int J Food Prop  2023,26(1),894-914","journal-title":"Int J Food Prop"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0974-2727.199625","volume":"9","author":"Buch A.","year":"2017","unstructured":"Buch A.; Kaur S.; Nair R.; Jain A.; Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J Lab Physicians  2017,9(2),84-88","journal-title":"J Lab Physicians"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","volume":"25","author":"Finkel R.","year":"2015","unstructured":"Finkel R.; Bertini E.; Muntoni F.; Mercuri E.; 209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7\u20139 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord  2015,25(7),593-602","journal-title":"Neuromuscul Disord"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/ane.13650","volume":"146","author":"Rossor A.M.","year":"2022","unstructured":"Rossor A.M.; Reilly M.M.; Blood biomarkers of peripheral neuropathy. Acta Neurol Scand  2022,146(4),325-331","journal-title":"Acta Neurol Scand"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2014.11.020","volume":"585","author":"Zhu T.","year":"2015","unstructured":"Zhu T.; Meng Q.; Ji J.; Lou X.; Zhang L.; Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathy. Neurosci Lett  2015,585,28-32","journal-title":"Neurosci Lett"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21608\/ejhm.2021.144904","volume":"82","author":"Abd El-hafez F.F.","year":"2021","unstructured":"Abd El-hafez F.F.; Nsr-Allah A.A.e.M.; Mohamed A.K.A.E.; Ahmed A.M.; Mahmoud A.A.; Mahmoud A.A.; Novel biomarker serum calprotectin for early diagnosis of diabetic peripheral neuropathy in Type 2 diabetes patients. Egypt J Hosp Med  2021,82(2),379-385","journal-title":"Egypt J Hosp Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10787-021-00919-3","volume":"30","author":"Aghamiri S.H.","year":"2022","unstructured":"Aghamiri S.H.; Komlakh K.; Ghaffari M.; The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy. Inflammopharmacology  2022,30(1),51-60","journal-title":"Inflammopharmacology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"104087","DOI":"10.1016\/j.drudis.2024.104087","volume":"29","author":"Chong Z.Z.","year":"2024","unstructured":"Chong Z.Z.; Menkes D.L.; Souayah N.; Targeting neuroinflammation in distal symmetrical polyneuropathy in diabetes. Drug Discov Today  2024,29(8),104087","journal-title":"Drug Discov Today"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"100946","DOI":"10.1016\/j.jpha.2024.01.014","volume":"14","author":"Wu J.","year":"2024","unstructured":"Wu J.; Li K.; Zhou M.; Gao H.; Wang W.; Xiao W.; Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. J Pharm Anal  2024,14(8),100946","journal-title":"J Pharm Anal"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/stcltm\/szad015","volume":"12","author":"Terashima T.","year":"2023","unstructured":"Terashima T.; Katagi M.; Ohashi N.; Neuronal-hematopoietic cell fusion in diabetic neuropathy. Stem Cells Transl Med  2023,12(4),215-220","journal-title":"Stem Cells Transl Med"},{"key":"ref=27","first-page":"1132","volume":"12","author":"Verma S.K.","year":"2023","unstructured":"Verma S.K.; Kishore J.; Kumari U.; A comparative study of tnf-alpha and IL-6 as potential biomarkers for patients with diabetic neuropathy. Int J Life Sci Biotechnol Pharma Res  2023,12(3),1132-1134","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41983-019-0080-0","volume":"55","author":"El Sheikh W.M.","year":"2019","unstructured":"El Sheikh W.M.; Alahmar I.E.; Salem G.M.; El-Sheikh M.A.; Tumor necrosis factor alpha in peripheral neuropathy in type 2 diabetes mellitus. Egypt J Neurol Psychiat Neurosurg  2019,55(1),37","journal-title":"Egypt J Neurol Psychiat Neurosurg"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/1742-2094-10-69","volume":"10","author":"Shi X.","year":"2013","unstructured":"Shi X.; Chen Y.; Nadeem L.; Xu G.; Beneficial effect of TNF-\u03b1 inhibition on diabetic peripheral neuropathy. J Neuroinflammation  2013,10(1),836","journal-title":"J Neuroinflammation"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.2147\/DMSO.S319863","volume":"14","author":"Mussa B.M.","year":"2021","unstructured":"Mussa B.M.; Srivastava A.; Al-Habshi A.; Mohammed A.K.; Halwani R.; Abusnana S.; Inflammatory biomarkers levels in T2DM emirati patients with diabetic neuropathy. Diabetes Metab Syndr Obes  2021,14,3389-3397","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2741\/4593","volume":"23","author":"Qi M.","year":"2018","unstructured":"Qi M.; Zhou Q.; Zeng W.; Wu L.; Zhao S.; Chen W.; Luo C.; Shen M.; Zhang J.; Tang C.E.; Growth factors in the pathogenesis of diabetic foot ulcers. front Biosci (Landmark Ed)  2018,23(2),310-317","journal-title":"front Biosci (Landmark Ed)"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1681\/ASN.2015111230","volume":"28","author":"Voelker J.","year":"2017","unstructured":"Voelker J.; Berg P.H.; Sheetz M.; Duffin K.; Shen T.; Moser B.; Greene T.; Blumenthal S.S.; Rychlik I.; Yagil Y.; Zaoui P.; Lewis J.B.; Anti\u2013TGF-\u03b21 antibody therapy in patients with diabetic nephropathy. J Am Soc Nephrol  2017,28(3),953-962","journal-title":"J Am Soc Nephrol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"Massagu\u00e9 J.","year":"2008","unstructured":"Massagu\u00e9 J.; TGF\u03b2 in cancer. Cell  2008,134(2),215-230","journal-title":"Cell"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","volume":"25","author":"Antonelli A.","year":"2014","unstructured":"Antonelli A.; Ferrari S.M.; Corrado A.; Ferrannini E.; Fallahi P.; CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev  2014,25(1),57-65","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e14302","DOI":"10.1111\/ijcp.14302","volume":"75","author":"Ascaso P.","year":"2021","unstructured":"Ascaso P.; Palanca A.; Martinez-Herv\u00e1s S.; Sanz M.J.; Ascaso J.F.; Piqueras L.; Real J.T.; Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes. Int J Clin Pract  2021,75(8),e14302","journal-title":"Int J Clin Pract"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"Gon\u00e7alves N.P.","year":"2017","unstructured":"Gon\u00e7alves N.P.; V\u00e6gter C.B.; Andersen H.; \u00d8stergaard L.; Calcutt N.A.; Jensen T.S.; Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol  2017,13(3),135-147","journal-title":"Nat Rev Neurol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","volume":"60","author":"Panee J.","year":"2012","unstructured":"Panee J.; Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine  2012,60(1),1-12","journal-title":"Cytokine"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.2353\/ajpath.2010.090694","volume":"176","author":"Kohl B.","year":"2010","unstructured":"Kohl B.; Fischer S.; Groh J.; Wessig C.; Martini R.; MCP-1\/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. Am J Pathol  2010,176(3),1390-1399","journal-title":"Am J Pathol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/glia.20657","volume":"56","author":"Fischer S.","year":"2008","unstructured":"Fischer S.; Weishaupt A.; Troppmair J.; Martini R.; Increase of MCP\u20101 (CCL2) in myelin mutant Schwann cells is mediated by MEK\u2010ERK signaling pathway. Glia  2008,56(8),836-843","journal-title":"Glia"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"995","DOI":"10.21608\/ejhm.2021.160038","volume":"83","author":"Mahmoud A.A.","year":"2021","unstructured":"Mahmoud A.A.; Soliman M.S.; Moustafa A.; Evaluation of monocyte chemoattractant protein 1 (MCP-1) as a predictor of complications in type 2 diabetes mellitus in Zagazig University Hospital. Egypt J Hosp Med  2021,83(1),995-1001","journal-title":"Egypt J Hosp Med"},{"key":"ref=41","first-page":"12","volume":"18","author":"Karahmet E.","year":"2021","unstructured":"Karahmet E.; Prnjavorac B.; Bego T.; Softi\u0107 A.; Begi\u0107 L.; Begi\u0107 E.; Karahmet E.; Prnjavorac L.; Prnjavorac I.; Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy. Med Glas  2021,18(1),12-17","journal-title":"Med Glas"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fendo.2017.00089","volume":"8","author":"Cox A.A.","year":"2017","unstructured":"Cox A.A.; Sagot Y.; Hedou G.; Grek C.; Wilkes T.; Vinik A.I.; Ghatnekar G.; Low-dose pulsatile interleukin-6 as a treatment option for diabetic peripheral neuropathy. Front Endocrinol (Lausanne)  2017,8,89","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e21952","DOI":"10.7759\/cureus.21952","volume":"14","author":"Chanda D.","year":"2022","unstructured":"Chanda D.; Ray S.; Chakraborti D.; Sen S.; Mitra A.; Interleukin-6 levels in patients with diabetic polyneuropathy. Cureus  2022,14(2),e21952","journal-title":"Cureus"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s12035-013-8537-0","volume":"49","author":"Zhou J.","year":"2014","unstructured":"Zhou J.; Zhou S.; Inflammation: Therapeutic targets for diabetic neuropathy. Mol Neurobiol  2014,49(1),536-546","journal-title":"Mol Neurobiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3390\/life13091861","volume":"13","author":"Mure\u0219an A.V.","year":"2023","unstructured":"Mure\u0219an A.V.; Tomac A.; Opri\u0219 D.R.; Bandici B.C.; Co\u0219arc\u0103 C.M.; Covalcic D.C.; H\u0103lmaciu I.; Ak\u00e1csos-Sz\u00e1sz O.Z.; R\u0103dulescu F.; L\u00e1z\u00e1r K.; Stoian A.; Tilinca M.C.; Inflammatory markers used as predictors of subclinical atherosclerosis in patients with diabetic polyneuropathy. Life (Basel)  2023,13(9),1861","journal-title":"Life (Basel)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2020.1837183","author":"Adki K.M.","year":"2020","unstructured":"Adki K.M.; Kulkarni Y.A.; Biomarkers in diabetic neuropathy. Arch Physiol Biochem  2020,1-16","journal-title":"Arch Physiol Biochem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"567959","DOI":"10.3389\/fendo.2020.567959","volume":"11","author":"Sun Q.","year":"2020","unstructured":"Sun Q.; Yan B.; Yang D.; Guo J.; Wang C.; Zhang Q.; Shi Y.; Shi X.; Tian G.; Liang X.; Serum adiponectin levels are positively associated with diabetic peripheral neuropathy in chinese patients with type 2 diabetes. Front Endocrinol (Lausanne)  2020,11,567959","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.35975\/apic.v28i3.2475","volume":"28","author":"Al-Dulaimy A.H.","year":"2024","unstructured":"Al-Dulaimy A.H.; Abdul Ghafoor K.F.; Evaluation of adiponectin serum levels and their association with oxidative stress in individuals with type 2 diabetes mellitus in Iraq. Anaesth Pain Intensive Care  2024,28(3),553-557","journal-title":"Anaesth Pain Intensive Care"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2350-2-4","volume":"2","author":"Chistyakov D.A.","year":"2001","unstructured":"Chistyakov D.A.; Savost\u2019anov K.V.; Zotova E.V.; Nosikov V.V.; Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet  2001,2(1),4","journal-title":"BMC Med Genet"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1210\/er.2003-0019","volume":"25","author":"Vincent A.M.","year":"2004","unstructured":"Vincent A.M.; Russell J.W.; Low P.; Feldman E.L.; Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev  2004,25(4),612-628","journal-title":"Endocr Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"378790","DOI":"10.1155\/2013\/378790","volume":"2013","author":"Tiwari B.K.","year":"2013","unstructured":"Tiwari B.K.; Pandey K.B.; Abidi A.B.; Rizvi S.I.; Markers of oxidative stress during diabetes mellitus. J Biomark  2013,2013,378790","journal-title":"J Biomark"},{"key":"ref=52","first-page":"2362","volume":"3","author":"Dayanand C.D.","year":"2012","unstructured":"Dayanand C.D.; Vegi P.K.; Kutty A.V.; Protein carbonyl content as a stable oxidative stress marker in type II diabetes. Int J Biol Med Res  2012,3(4),2362-2365","journal-title":"Int J Biol Med Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/pin.13458","volume":"74","author":"Mizukami H.","year":"2024","unstructured":"Mizukami H.; Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy. Pathol Int  2024,74(8),438-453","journal-title":"Pathol Int"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","volume":"24","author":"Masenga S.K.","year":"2023","unstructured":"Masenga S.K.; Kabwe L.S.; Chakulya M.; Kirabo A.; Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci  2023,24(9),7898","journal-title":"Int J Mol Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s43032-022-01056-0","volume":"30","author":"Kl\u00f6ppel E.","year":"2023","unstructured":"Kl\u00f6ppel E.; Sinzato Y.K.; Rodrigues T.; Gallego F.Q.; Karki B.; Volpato G.T.; Corrente J.E.; Roy S.; Damasceno D.C.; Benefits of vitamin D supplementation on pregnancy of rats with pregestational diabetes and their offspring. Reprod Sci  2023,30(4),1241-1256","journal-title":"Reprod Sci"},{"key":"ref=56","first-page":"14","volume":"35","author":"Spirlandeli A.L.","year":"2014","unstructured":"Spirlandeli A.L.; Deminice R.; Jordao A.A.; Plasma malondialdehyde as biomarker of lipid peroxidation: effects of acute exercise. Int J Sports Med  2014,35(1),14-18","journal-title":"Int J Sports Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/ijms11114631","volume":"11","author":"Janicka M.","year":"2010","unstructured":"Janicka M.; Kot-Wasik A.; Kot J.; Namie\u015bnik J.; Isoprostanes-biomarkers of lipid peroxidation: Their utility in evaluating oxidative stress and analysis. Int J Mol Sci  2010,11(11),4631-4659","journal-title":"Int J Mol Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.bbagen.2013.03.020","volume":"1840","year":"2014","unstructured":"Subjects, General Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta  2014,1840(2),809-817","journal-title":"Biochim Biophys Acta"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3164\/jcbn.14-10","volume":"54","author":"Shichiri M.","year":"2014","unstructured":"Shichiri M.; The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr  2014,54(3),151-160","journal-title":"J Clin Biochem Nutr"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168","author":"Pushpakom S.","year":"2018","unstructured":"Pushpakom S.; Iorio F.; Eyers P.A.; Escott K.J.; Hopper S.; Wells A.; Drug repurposing: Progress, challenges and recommendations. Nat Rev Drug Discov  2018","journal-title":"Nat Rev Drug Discov"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1352803","DOI":"10.3389\/fmed.2024.1352803","volume":"11","author":"Jonker A.H.","year":"2024","unstructured":"Jonker A.H.; O\u2019Connor D.; Cavaller-Bellaubi M.; Fetro C.; Gogou M.; \u2019T Hoen, P.A.C.; de Kort, M.; Stone, H.; Valentine, N.; Pasmooij, A.M.G. Drug repurposing for rare: Progress and opportunities for the rare disease community. Front Med (Lausanne)  2024,11,1352803","journal-title":"Front Med (Lausanne)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","volume":"14","author":"Oprea T.I.","year":"2012","unstructured":"Oprea T.I.; Mestres J.; Drug repurposing: Far beyond new targets for old drugs. AAPS J  2012,14(4),759-763","journal-title":"AAPS J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","volume":"24","author":"Parvathaneni V.","year":"2019","unstructured":"Parvathaneni V.; Kulkarni N.S.; Muth A.; Gupta V.; Drug repurposing: A promising tool to accelerate the drug discovery process. Drug Discov Today  2019,24(10),2076-2085","journal-title":"Drug Discov Today"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"Corsello S.M.","year":"2017","unstructured":"Corsello S.M.; Bittker J.A.; Liu Z.; Gould J.; McCarren P.; Hirschman J.E.; Johnston S.E.; Vrcic A.; Wong B.; Khan M.; Asiedu J.; Narayan R.; Mader C.C.; Subramanian A.; Golub T.R.; The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med  2017,23(4),405-408","journal-title":"Nat Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.ygeno.2019.06.021","volume":"112","author":"Masoudi-Sobhanzadeh Y.","year":"2020","unstructured":"Masoudi-Sobhanzadeh Y.; Omidi Y.; Amanlou M.; Masoudi-Nejad A.; Drug databases and their contributions to drug repurposing. Genomics  2020,112(2),1087-1095","journal-title":"Genomics"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","volume":"42","author":"Roessler H.I.","year":"2021","unstructured":"Roessler H.I.; Knoers N.V.A.M.; van Haelst M.M.; van Haaften G.; Drug repurposing for rare diseases. Trends Pharmacol Sci  2021,42(4),255-267","journal-title":"Trends Pharmacol Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"111638","DOI":"10.1016\/j.biopha.2021.111638","volume":"141","author":"Sonaye H.V.","year":"2021","unstructured":"Sonaye H.V.; Sheikh R.Y.; Doifode C.A.; Drug repurposing: Iron in the fire for older drugs. Biomed Pharmacother  2021,141,111638","journal-title":"Biomed Pharmacother"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"113846","DOI":"10.1016\/j.biopha.2022.113846","volume":"156","author":"Paul A.","year":"2022","unstructured":"Paul A.; Kumar M.; Das P.; Guha N.; Rudrapal M.; Zaman M.K.; Drug repurposing \u2013 A search for novel therapy for the treatment of diabetic neuropathy. Biomed Pharmacother  2022,156,113846","journal-title":"Biomed Pharmacother"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.5_suppl_2.S14","volume":"59","author":"Backonja M.M.","year":"2002","unstructured":"Backonja M.M.; Use of anticonvulsants for treatment of neuropathic pain. Neurology  (Suppl. 2), S14-S17.2002,59(5_suppl_2)","journal-title":"Neurology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","volume":"63","author":"Raskin P.","year":"2004","unstructured":"Raskin P.; Donofrio P.D.; Rosenthal N.R.; Hewitt D.J.; Jordan D.M.; Xiang J.; Vinik A.I.; Topiramate vs placebo in painful diabetic neuropathy. Neurology  2004,63(5),865-873","journal-title":"Neurology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.podrm.2015.11.001","volume":"41","author":"Alrashood S.T.","year":"2016","unstructured":"Alrashood S.T.; Carbamazepine. Profiles Drug Subst Excip Relat Methodol  2016,41,133-321","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/brainsci13010123","volume":"13","author":"Dyong T.M.","year":"2023","unstructured":"Dyong T.M.; Gess B.; Dumke C.; Rolke R.; Dohrn M.F.; Carbamazepine for chronic muscle pain: A retrospective assessment of indications, side effects, and treatment response. Brain Sci  2023,13(1),123","journal-title":"Brain Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"743","DOI":"10.4093\/dmj.2023.0018","volume":"47","author":"Jang H.N.","year":"2023","unstructured":"Jang H.N.; Oh T.J.; Pharmacological and nonpharmacological treatments for painful diabetic peripheral neuropathy. Diabetes Metab J  2023,47(6),743-756","journal-title":"Diabetes Metab J"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/papr.13165","volume":"23","author":"Russo M.","year":"2023","unstructured":"Russo M.; Graham B.; Santarelli D.M.; Gabapentin \u2014 Friend or foe? Pain Pract  2023,23(1),63-69","journal-title":"Pain Pract"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"390","DOI":"10.21037\/apm-22-693","volume":"12","author":"Chang M.C.","year":"2023","unstructured":"Chang M.C.; Yang S.; Diabetic peripheral neuropathy essentials: A narrative review. Ann Palliat Med  2023,12(2),390-398","journal-title":"Ann Palliat Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/biomedicines11071924","volume":"11","author":"Mokhtar N.","year":"2023","unstructured":"Mokhtar N.; Doly S.; Courteix C.; Diabetic neuropathic pain and serotonin: What is new in the last 15 years? Biomedicines  2023,11(7),1924","journal-title":"Biomedicines"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/978-3-031-15613-7_25","author":"Gylfadottir S.S.","year":"2023;","unstructured":"Gylfadottir S.S.; Finnerup N.B.;  In: Diabetic Neuropathy  2023;,441-452","journal-title":"In: Diabetic Neuropathy"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"129472","DOI":"10.1016\/j.bmcl.2023.129472","volume":"95","author":"Micheli L.","year":"2023","unstructured":"Micheli L.; Rajamoni J.; Di Cesare Mannelli L.; Rajagopalan P.; Ghelardini C.; Rajagopalan R.; DDD-028: A potent, neuroprotective, non-opioid compound for the treatment of diabetic neuropathy. Bioorg Med Chem Lett  2023,95,129472","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=79","first-page":"223","volume":"7","author":"Sagar T.V.","year":"2022","unstructured":"Sagar T.V.; Yatish B.; Safety and efficacy of duloxetine versus gabapentin in painful diabetic polyneuropathy. IP Int J Compr Adv Pharmacol  2022,7(4),223-227","journal-title":"IP Int J Compr Adv Pharmacol"},{"key":"ref=80","first-page":"3","volume":"4","author":"Nugroho A.","year":"2023","unstructured":"Nugroho A.; Irfana L.; Triastuti N.; Indrawati N.D.; Effectiveness of anticonvulsants compared to antidepressants in reducing pain in diabetic neuropathy complications. Borneo Rev Med Sci  2023,4(1),3-11","journal-title":"Borneo Rev Med Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"e0287373","DOI":"10.1371\/journal.pone.0287373","volume":"18","author":"Chang K.C.","year":"2023","unstructured":"Chang K.C.; Pai Y.W.; Lin C.H.; Lee I.T.; Chang M.H.; The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. PLoS One  2023,18(6),e0287373","journal-title":"PLoS One"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.neuron.2023.05.003","volume":"111","author":"Eid S.A.","year":"2023","unstructured":"Eid S.A.; Rumora A.E.; Beirowski B.; Bennett D.L.; Hur J.; Savelieff M.G.; Feldman E.L.; New perspectives in diabetic neuropathy. Neuron  2023,111(17),2623-2641","journal-title":"Neuron"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1239335","DOI":"10.3389\/fendo.2023.1239335","volume":"14","author":"Laakso M.","year":"2023","unstructured":"Laakso M.; Fernandes Silva L.; Statins and risk of type 2 diabetes: Mechanism and clinical implications. Front Endocrinol (Lausanne)  2023,14,1239335","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s13340-023-00629-x","volume":"14","author":"Goh J.K.","year":"2023","unstructured":"Goh J.K.; Koh L.; Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: A systematic review. Diabetol Int  2023,14(3),224-242","journal-title":"Diabetol Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-3-031-13009-0_19","author":"Cohen S.D.","year":"2023","unstructured":"Cohen S.D.; Faselis C.;  In: Blood Pressure Disorders in Diabetes Mellitus  2023,327-335","journal-title":"In: Blood Pressure Disorders in Diabetes Mellitus"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-3-031-13009-0_26","author":"Mancia G.","year":"2023","unstructured":"Mancia G.; Seravalle G.; Grassi G.; Diabetogenic effects of antihypertensive drugs and statins. Blood Pressure Disorders in Diabetes Mellitus  2023,421-435","journal-title":"Blood Pressure Disorders in Diabetes Mellitus"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.expneurol.2008.12.012","volume":"216","author":"Choi J.S.","year":"2009","unstructured":"Choi J.S.; Zhang L.; Dib-Hajj S.D.; Han C.; Tyrrell L.; Lin Z.; Wang X.; Yang Y.; Waxman S.G.; Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off. Exp Neurol  2009,216(2),383-389","journal-title":"Exp Neurol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"116417","DOI":"10.1016\/j.biopha.2024.116417","volume":"173","author":"Wang Q.","year":"2024","unstructured":"Wang Q.; Ye Y.; Yang L.; Xiao L.; Liu J.; Zhang W.; Du G.; Painful diabetic neuropathy: The role of ion channels. Biomed Pharmacother  2024,173,116417","journal-title":"Biomed Pharmacother"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1423-0127-20-23","volume":"20","author":"Chen Y.F.","year":"2013","unstructured":"Chen Y.F.; Chen Y.T.; Chiu W.T.; Shen M.R.; Remodeling of calcium signaling in tumor progression. J Biomed Sci  2013,20(1),23","journal-title":"J Biomed Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40265-022-01689-0","volume":"82","author":"Sisignano M.","year":"2022","unstructured":"Sisignano M.; Gribbon P.; Geisslinger G.; Drug repurposing to target neuroinflammation and sensory neuron-dependent pain. Drugs  2022,82(4),357-373","journal-title":"Drugs"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"17448","DOI":"10.1039\/D4RA02349H","volume":"14","author":"Bennici G.","year":"2024","unstructured":"Bennici G.; Almahasheer H.; Alghrably M.; Valensin D.; Kola A.; Kokotidou C.; Lachowicz J.; Jaremko M.; Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions. RSC Advances  2024,14(25),17448-17460","journal-title":"RSC Advances"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.3390\/ijms25147783","volume":"25","author":"Chianese D.","year":"2024","unstructured":"Chianese D.; Bonora M.; Sambataro M.; Sambato L.; Paola L.D.; Tremoli E.; Cappucci I.P.; Scatto M.; Pinton P.; Picari M.; Ferroni L.; Zavan B.; Exploring mitochondrial interactions with pulsed electromagnetic fields: An insightful inquiry into strategies for addressing neuroinflammation and oxidative stress in diabetic neuropathy. Int J Mol Sci  2024,25(14),7783","journal-title":"Int J Mol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000003077","volume":"132","author":"Li J.","year":"2020","unstructured":"Li J.; Ma J.; Lacagnina M.J.; Lorca S.; Odem M.A.; Walters E.T.; Kavelaars A.; Grace P.M.; Oral dimethyl fumarate reduces peripheral neuropathic pain in rodents via NFE2L2 antioxidant signaling. Anesthesiology  2020,132(2),343-356","journal-title":"Anesthesiology"},{"key":"ref=94","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998242299231011181615","author":"Aziz N.","year":"2023","unstructured":"Aziz N.; Dash B.; Wal P.; Kumari P.; Joshi P.; Wal A.; New horizons in diabetic neuropathies: An updated review on their pathology, diagnosis, mechanism, screening techniques, pharmacological, and future approaches. Curr Diabetes Rev  2023","journal-title":"Curr Diabetes Rev"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"Zhu J.","year":"2024","unstructured":"Zhu J.; Hu Z.; Luo Y.; Liu Y.; Luo W.; Du X.; Luo Z.; Hu J.; Peng S.; Diabetic peripheral neuropathy: Pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne)  2024,14,1265372","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"176749","DOI":"10.1016\/j.ejphar.2024.176749","volume":"978","author":"Chen W.","year":"2024","unstructured":"Chen W.; Wu J.Y.; Fan Y.Y.; Li B.L.; Yuan H.B.; Zhao X.; Purpurin ameliorated neuropathic allodynia and hyperalgesia by modulating neuronal mitochondrial bioenergetics and redox status in type 1 diabetic mice. Eur J Pharmacol  2024,978,176749","journal-title":"Eur J Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/pmt-2023-0006","volume":"13","author":"Goodwin B.","year":"2023","unstructured":"Goodwin B.; Chiplunkar M.; Salerno R.; Coombs K.; Sannoh U.; Shah V.; Averell N.; Al-Shebab U.; Janora D.; Topical capsaicin for the management of painful diabetic neuropathy: A narrative systematic review. Pain Manag (Lond)  2023,13(5),309-316","journal-title":"Pain Manag (Lond)"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3892\/mmr.2024.13162","volume":"29","author":"Zhang W.","year":"2024","unstructured":"Zhang W.; Zhang Y.; Fan J.; Feng Z.; Song X.; Pharmacological activity of capsaicin: Mechanisms and controversies(Review). Mol Med Rep  2024,29(3),38","journal-title":"Mol Med Rep"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1080\/10408398.2021.1991883","volume":"63","author":"Liang W.","year":"2023","unstructured":"Liang W.; Lan Y.; Chen C.; Song M.; Xiao J.; Huang Q.; Cao Y.; Ho C.T.; Lu M.; Modulating effects of capsaicin on glucose homeostasis and the underlying mechanism. Crit Rev Food Sci Nutr  2023,63(19),3634-3652","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bja.2023.04.021","volume":"131","author":"Attal N.","year":"2023","unstructured":"Attal N.; Bouhassira D.; Colvin L.; Advances and challenges in neuropathic pain: A narrative review and future directions. Br J Anaesth  2023,131(1),79-92","journal-title":"Br J Anaesth"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.53043\/NDCR-3-004","volume":"3","author":"Hassan A.I.","year":"2023","unstructured":"Hassan A.I.; Revolutionary approaches to managing neuropathies: A review of innovative therapies. Neurodegener Dis Cur Res  2023,3(1),1-8","journal-title":"Neurodegener Dis Cur Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/gels9050417","volume":"9","author":"Pu\u0219ca\u0219u C.","year":"2023","unstructured":"Pu\u0219ca\u0219u C.; Zanfirescu A.; Negre\u0219 S.; Recent progress in gels for neuropathic pain. Gels  2023,9(5),417","journal-title":"Gels"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/nu15061537","volume":"15","author":"Thornton T.","year":"2023","unstructured":"Thornton T.; Mills D.; Bliss E.; Capsaicin: A Potential treatment to improve cerebrovascular function and cognition in obesity and ageing. Nutrients  2023,15(6),1537","journal-title":"Nutrients"},{"key":"ref=104","unstructured":"Managing pain after stroke: A review of the literature.  Available from:  http:\/\/ochsner-craft.s3.amazonaws.com\/education\/static\/Hanyu-Deutmeyer-Treating-Pain-in-Stroke-Patients-A-Review-Stroke-and-Pain.pdf"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"17448069231193368","DOI":"10.1177\/17448069231193368","volume":"19","author":"de Geus T.J.","year":"2023","unstructured":"de Geus T.J.; Franken G.; Joosten E.A.; Conventional, high frequency and differential targeted multiplexed spinal cord stimulation in experimental painful diabetic peripheral neuropathy: Pain behavior and role of the central inflammatory balance. Mol Pain  2023,19,17448069231193368","journal-title":"Mol Pain"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.neurom.2023.04.105","volume":"26","author":"Grigsby E.","year":"2023","unstructured":"Grigsby E.; Slangen R.; Johanek L.; LaRue M.; de Vos C.; Murphy M.ID; 215433 the history of spinal cord stimulation to treat painful diabetic peripheral neuropathy. Neuromodulation  2023,26(4),S61","journal-title":"Neuromodulation"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"e134901","DOI":"10.5812\/aapm-134901","volume":"13","author":"Amorizzo E.","year":"2023","unstructured":"Amorizzo E.; De Sanctis F.; Baldeschi G.C.; Fast-acting sub-perception spinal cord stimulation for a case of painful diabetic polyneuropathy. Anesth Pain Med  2023,13(2),e134901","journal-title":"Anesth Pain Med"},{"key":"ref=108","doi-asserted-by":"crossref","DOI":"10.5812\/aapm-134901","volume":"13","author":"Amorizzo E.","year":"2023","unstructured":"Amorizzo E.; De Sanctis F.; Baldeschi G.C.; Fast-acting sub-perception spinal cord stimulation for a case of painful diabetic polyneuropathy: A case report. Anesth Pain Med  2023,13(2)","journal-title":"Anesth Pain Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.neurom.2023.04.236","volume":"26","author":"Chen J.","year":"2023","unstructured":"Chen J.; Castellanos J.; Reddy R.; Furnish T.; Halter K.; Azalde R.; Frizzi K.; Calcutt N.ID; 212826 investigation of 10khz spinal cord stimulation on small fiber painful diabetic neuropathy (PDN). Neuromodulation  2023,26(4),S135","journal-title":"Neuromodulation"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/antiox12010123","volume":"12","author":"Akpoveso O.O.P.","year":"2023","unstructured":"Akpoveso O.O.P.; Ubah E.E.; Obasanmi G.; Antioxidant phytochemicals as potential therapy for diabetic complications. Antioxidants  2023,12(1),123","journal-title":"Antioxidants"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12968\/jowc.2023.32.4.238","volume":"32","author":"P\u00e9rez-Zabala E.","year":"2023","unstructured":"P\u00e9rez-Zabala E.; Basterretxea A.; Castro B.; Aizpuru A.; Arancon J.A.; Moreno C.; Zubizarreta A.; Larizgoitia Z.; Ysa A.; Lobato M.; Larrazabal A.; New antioxidant therapy for hard-to-heal neuroischaemic diabetic foot ulcers with deep exposure. J Wound Care  2023,32(4),238-246","journal-title":"J Wound Care"},{"key":"ref=112","doi-asserted-by":"publisher","DOI":"10.22452\/jummec.sp2023no2.45","author":"Rahman M.","year":"2023","unstructured":"Rahman M.; Ibrahim F.S.; Amom Z.; Amran A.A; The antioxidant mechanism in the prevention of type 2 diabetes and its complications: A narrative review. J Health Transl Med  2023(2)","journal-title":"J Health Transl Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e003179","DOI":"10.1136\/bmjdrc-2022-003179","volume":"11","author":"Tomah S.","year":"2023","unstructured":"Tomah S.; Zhang H.; Al-Badri M.; Salah T.; Dhaver S.; Khater A.; Tasabehji M.W.; Hamdy O.; Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: A 10-year longitudinal study. BMJ Open Diabetes Res Care  2023,11(3),e003179","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-15613-7_22","author":"Enders J.","year":"2023","unstructured":"Enders J.; Wright D.E.; Lifestyle and dietary modifications: Relevance in the management of diabetic neuropathy. Diabetic neuropathy  2023","journal-title":"Diabetic neuropathy"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1089\/ars.2022.0158","volume":"38","author":"Enders J.","year":"2023","unstructured":"Enders J.; Elliott D.; Wright D.E.; Emerging nonpharmacologic interventions to treat diabetic peripheral neuropathy. Antioxid Redox Signal  2023,38(13-15),989-1000","journal-title":"Antioxid Redox Signal"},{"key":"ref=116","author":"Wyatt C.R.","year":"2023","unstructured":"Wyatt C.R.; The effects of dietary and lifestyle management on diabetic neuropathy. Thesis, Liberty University  2023","journal-title":"Thesis, Liberty University"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/life12081125","volume":"12","author":"D\u2019Egidio F.","year":"2022","unstructured":"D\u2019Egidio F.; Lombardozzi G.; Kacem Ben Haj M\u2019Barek H.E.; Mastroiacovo G.; Alfonsetti M.; Cimini A.; The influence of dietary supplementations on neuropathic pain. Life (Basel)  2022,12(8),1125","journal-title":"Life (Basel)"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/life12081185","volume":"12","author":"Smith S.","year":"2022","unstructured":"Smith S.; Normahani P.; Lane T.; Hohenschurz-Schmidt D.; Oliver N.; Davies A.H.; Prevention and management strategies for diabetic neuropathy. Life (Basel)  2022,12(8),1185","journal-title":"Life (Basel)"},{"key":"ref=119","first-page":"1071","volume":"6","author":"Sudhan P.","year":"2023","unstructured":"Sudhan P.; Subbiah B.; Rajagopalan N.; Sukumaran R.; Janaki G.; Ananthan B.; Effect of yoga therapy on neurological characteristics in diabetic peripheral neuropathy: Neuro health perspective. J. ReAttach Therapy Develop. Diversit  2023,6(10s(2)),1071-1078","journal-title":"Diversit"},{"key":"ref=120","first-page":"L230","volume":"13","author":"Sudhan P","year":"2023","unstructured":"Sudhan P; Subbiah B; Sukumaran R; Janaki G; Nagesh P; Kalpana L.; Efficacy of yoga therapy on psychological variables in male persons with diabetic peripheral neuropathy (DPN). Int J Life Sci Pharma Res  2023,13(1),L230-L244","journal-title":"Int J Life Sci Pharma Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7324\/JAPS.2023.141927","volume":"13","year":"2023","unstructured":"Syuhada.; Anggadiredja, K; Kurniati, NF; Akrom. The Potential of Nigella sativa oil on clinical output improvement of diabetic neuropathy. J Appl Pharm Sci  2023,13(9),9-17","journal-title":"J Appl Pharm Sci"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"e43697","DOI":"10.7759\/cureus.43697","volume":"15","author":"Sugandh F.N.U.","year":"2023","unstructured":"Sugandh F.N.U.; Chandio M.; Raveena F.N.U.; Kumar L.; Karishma F.N.U.; Khuwaja S.; Memon U.A.; Bai K.; Kashif M.; Varrassi G.; Khatri M.; Kumar S.; Advances in the management of diabetes mellitus: A focus on personalized medicine. Cureus  2023,15(8),e43697","journal-title":"Cureus"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","volume":"9","author":"Simonato M.","year":"2013","unstructured":"Simonato M.; Bennett J.; Boulis N.M.; Castro M.G.; Fink D.J.; Goins W.F.; Gray S.J.; Lowenstein P.R.; Vandenberghe L.H.; Wilson T.J.; Wolfe J.H.; Glorioso J.C.; Progress in gene therapy for neurological disorders. Nat Rev Neurol  2013,9(5),277-291","journal-title":"Nat Rev Neurol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/156720111795256174","volume":"8","author":"Elsabahy M.","year":"2011","unstructured":"Elsabahy M.; Nazarali A.; Foldvari M.; Non-viral nucleic acid delivery: Key challenges and future directions. Curr Drug Deliv  2011,8(3),235-244","journal-title":"Curr Drug Deliv"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI42258","volume":"120","author":"den Hollander A.I.","year":"2010","unstructured":"den Hollander A.I.; Black A.; Bennett J.; Cremers F.P.M.; Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies. J Clin Invest  2010,120(9),3042-3053","journal-title":"J Clin Invest"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/gt.2011.172","volume":"19","author":"Farrar G.J.","year":"2012","unstructured":"Farrar G.J.; Millington-Ward S.; Chadderton N.; Humphries P.; Kenna P.F.; Gene-based therapies for dominantly inherited retinopathies. Gene Ther  2012,19(2),137-144","journal-title":"Gene Ther"},{"key":"ref=127","first-page":"1593","volume":"12","author":"Isner J.M.","year":"2001","unstructured":"Isner J.M.; Ropper A.; Hirst K.; VEGF gene transfer for diabetic neuropathy. Hum Gene Ther  2001,12(12),1593-1594","journal-title":"Hum Gene Ther"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1212\/01.WNL.0000171978.70849.c5","volume":"65","author":"Sahenk Z.","year":"2005","unstructured":"Sahenk Z.; Nagaraja H.N.; McCracken B.S.; King W.M.; Freimer M.L.; Cedarbaum J.M.; Mendell J.R.; NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology  2005,65(5),681-689","journal-title":"Neurology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/brainsci13020255","volume":"13","author":"Akter S.","year":"2023","unstructured":"Akter S.; Choubey M.; Mohib M.M.; Arbee S.; Sagor M.A.T.; Mohiuddin M.S.; Stem cell therapy in diabetic polyneuropathy: Recent advancements and future directions. Brain Sci  2023,13(2),255","journal-title":"Brain Sci"},{"key":"ref=130","first-page":"173","volume":"55","author":"Proch\u00e1zka V.","year":"2009","unstructured":"Proch\u00e1zka V.; Gumulec J.; Chmelov\u00e1 J.; Klement P.; Klement G.L.; Jonszta T.; Czern\u00fd D.; Krajca J.; Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek  2009,55(3),173-178","journal-title":"Vnitr Lek"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5966\/sctm.2011-0064","volume":"1","author":"Cuende N.","year":"2012","unstructured":"Cuende N.; Rico L.; Herrera C.; Concise review: Bone marrow mononuclear cells for the treatment of ischemic syndromes: Medicinal product or cell transplantation? Stem Cells Transl Med  2012,1(5),403-408","journal-title":"Stem Cells Transl Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/ars.2014.5931","volume":"21","author":"Ushio-Fukai M.","year":"2014","unstructured":"Ushio-Fukai M.; Rehman J.; Redox and metabolic regulation of stem\/progenitor cells and their niche. Antioxid Redox Signal  2014,21(11),1587-1590","journal-title":"Antioxid Redox Signal"},{"key":"ref=133","author":"Wal P.","year":"2023","unstructured":"Wal P.; Aziz N.; Prajapati H.; Soni S.; Wal A.; current landscape of various techniques and methods of gene therapy through CRISPR Cas9 along with its pharmacological and interventional therapies in the treatment of type 2 diabetes mellitus. Curr Diabetes Rev  2023","journal-title":"Curr Diabetes Rev"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"Pittenger M.F.","year":"1999","unstructured":"Pittenger M.F.; Mackay A.M.; Beck S.C.; Jaiswal R.K.; Douglas R.; Mosca J.D.; Moorman M.A.; Simonetti D.W.; Craig S.; Marshak D.R.; Multilineage potential of adult human mesenchymal stem cells. Science  1999,284(5411),143-147","journal-title":"Science"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","volume":"109","author":"Kinnaird T.","year":"2004","unstructured":"Kinnaird T.; Stabile E.; Burnett M.S.; Shou M.; Lee C.W.; Barr S.; Fuchs S.; Epstein S.E.; Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation  2004,109(12),1543-1549","journal-title":"Circulation"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.110.239848","volume":"108","author":"Jeong J.O.","year":"2011","unstructured":"Jeong J.O.; Han J.W.; Kim J.M.; Cho H.J.; Park C.; Lee N.; Kim D.W.; Yoon Y.S.; Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res  2011,108(11),1340-1347","journal-title":"Circ Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.113.003000","volume":"129","author":"Park T.S.","year":"2014","unstructured":"Park T.S.; Bhutto I.; Zimmerlin L.; Huo J.S.; Nagaria P.; Miller D.; Zambidis E.T.; Vascular progenitors from cord blood-derived iPSC possess augmented capacity for regenerating ischemic retinal vasculature. Circulation  2014,129,359-372","journal-title":"Circulation"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3727\/096368912X657710","volume":"22","author":"Okawa T.","year":"2013","unstructured":"Okawa T.; Kamiya H.; Himeno T.; Kato J.; Seino Y.; Fujiya A.; Kondo M.; Tsunekawa S.; Naruse K.; Hamada Y.; Ozaki N.; Cheng Z.; Kito T.; Suzuki H.; Ito S.; Oiso Y.; Nakamura J.; Isobe K.I.; Transplantation of neural crest-like cells derived from induced pluripotent stem cells improves diabetic polyneuropathy in mice. Cell Transplant  2013,22(10),1767-1783","journal-title":"Cell Transplant"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1582-4934.2008.00598.x","volume":"13","author":"Timmermans F.","year":"2009","unstructured":"Timmermans F.; Plum J.; Y\u00f6der M.C.; Ingram D.A.; Vandekerckhove B.; Case J.; Endothelial progenitor cells: Identity defined? J Cell Mol Med  2009,13(1),87-102","journal-title":"J Cell Mol Med"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood.V92.2.362","volume":"92","author":"Shi Q.","year":"1998","unstructured":"Shi Q.; Rafii S.; Wu M.H.D.; Wijelath E.S.; Yu C.; Ishida A.; Fujita Y.; Kothari S.; Mohle R.; Sauvage L.R.; Moore M.A.S.; Storb R.F.; Hammond W.P.; Evidence for circulating bone marrow-derived endothelial cells. Blood  1998,92(2),362-367","journal-title":"Blood"},{"key":"ref=141","first-page":"10","volume":"229","author":"Basile D.P.","year":"2014","unstructured":"Basile D.P.; Yoder M.C.; Circulating and tissue resident endothelial progenitor cells. J Cell Physiol  2014,229(1),10-16","journal-title":"J Cell Physiol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/01.RES.0000189259.69645.25","volume":"97","author":"O\u2019Neill T.J.","year":"2005","unstructured":"O\u2019Neill T.J.; Wamhoff B.R.; Owens G.K.; Skalak T.C.; Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res  2005,97(10),1027-1035","journal-title":"Circ Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1378\/chest.10-3327","volume":"140","author":"Belvisi M.G.","year":"2011","unstructured":"Belvisi M.G.; Dubuis E.; Birrell M.A.; Transient receptor potential A1 channels: Insights into cough and airway inflammatory disease. Chest  2011,140(4),1040-1047","journal-title":"Chest"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/bph.13514","volume":"173","author":"Baskaran P.","year":"2016","unstructured":"Baskaran P.; Krishnan V.; Ren J.; Thyagarajan B.; Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel\u2010dependent mechanisms. Br J Pharmacol  2016,173(15),2369-2389","journal-title":"Br J Pharmacol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/ph9040066","volume":"9","author":"Chung M.K.","year":"2016","unstructured":"Chung M.K.; Campbell J.; Use of capsaicin to treat pain: Mechanistic and therapeutic considerations. Pharmaceuticals (Basel)  2016,9(4),66","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"12692","DOI":"10.1038\/s41598-019-49070-8","volume":"9","author":"Wu N.","year":"2019","unstructured":"Wu N.; Nishioka W.K.; Derecki N.C.; Maher M.P.; High-throughput-compatible assays using a genetically-encoded calcium indicator. Sci Rep  2019,9(1),12692","journal-title":"Sci Rep"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010316518240924071259","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234593\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010316518240924071259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:08:04Z","timestamp":1764324484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234593\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":146,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010316518240924071259","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}